Oliver Mueller has been appointed president of Suzhou Pharma Services, an affiliate of Amerigen Pharmaceuticals. Suzhou is a contract development and manufacturing organization focused on oral solid dose forms, and is headquartered at the company’s corporate offices in NJ. The company’s primary manufacturing facility is located in Suzhou, China and is FDA- and Chinese sFDA-approved for finished dose manufacturing.
    
“Our mission at Suzhou Pharma Services is to provide our customers innovative and reliable solutions to their oral solid dose development and manufacturing needs, under the highest levels of quality and customer service standards available in the industry. We combine Western pharmaceutical experience, expertise and quality standards with Chinese production and cost efficiency, and as one of the first finished dose Chinese facilities approved by the FDA, we offer a very attractive value proposition,” said Mr. Mueller.